Literature DB >> 21477399

Nocturnal enuresis.

Darcie Kiddoo1.   

Abstract

INTRODUCTION: Nocturnal enuresis affects 15% to 20% of 5-year-old children, 5% of 10-year-old children, and 1% to 2% of people aged 15 years and over. Without treatment, 15% of affected children will become dry each year. Nocturnal enuresis is not diagnosed in children younger than 5 years, and treatment may be inappropriate for children younger than 7 years. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of interventions for relief of symptoms? We searched: Medline, Embase, The Cochrane Library, and other important databases up to February 2010 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 19 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: acupuncture, anticholinergics (oxybutynin, tolterodine, hyoscyamine), desmopressin, dry bed training, enuresis alarm, hypnotherapy, standard home alarm clock, and tricyclics (imipramine, desipramine).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21477399      PMCID: PMC3275307     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  18 in total

1.  Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis.

Authors:  C Radmayr; A Schlager; M Studen; G Bartsch
Journal:  Eur Urol       Date:  2001-08       Impact factor: 20.096

2.  Nocturnal enuresis is linked to a specific gene.

Authors:  H Eiberg
Journal:  Scand J Urol Nephrol Suppl       Date:  1995

3.  Total genome scan analysis in a single extended family for primary nocturnal enuresis: evidence for a new locus (ENUR3) for primary nocturnal enuresis on chromosome 22q11.

Authors:  H Eiberg
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

Review 4.  Fifty years of enuretic alarms.

Authors:  W I Forsythe; R J Butler
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

5.  Enuresis and spontaneous cure rate. Study of 1129 enuretis.

Authors:  W I Forsythe; A Redmond
Journal:  Arch Dis Child       Date:  1974-04       Impact factor: 3.791

6.  Hypnotherapy as a treatment for enuresis.

Authors:  S D Edwards; H I van der Spuy
Journal:  J Child Psychol Psychiatry       Date:  1985-01       Impact factor: 8.982

7.  The genetics of primary nocturnal enuresis: inheritance and suggestion of a second major gene on chromosome 12q.

Authors:  H Arnell; K Hjälmås; M Jägervall; G Läckgren; A Stenberg; B Bengtsson; C Wassén; T Emahazion; G Annerén; U Pettersson; M Sundvall; N Dahl
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

Review 8.  Side effects and complications of treatment with desmopressin for enuresis.

Authors:  W L Robson; A K Leung
Journal:  J Natl Med Assoc       Date:  1994-10       Impact factor: 1.798

9.  The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis.

Authors:  H G Rushton; A B Belman; M R Zaontz; S J Skoog; S Sihelnik
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

10.  Assignment of dominant inherited nocturnal enuresis (ENUR1) to chromosome 13q.

Authors:  H Eiberg; I Berendt; J Mohr
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

View more
  3 in total

1.  Desmopressin, Imipramine, and Oxybutynin in the Treatment of Primary Nocturnal Enuresis: A Randomized Clinical Trial.

Authors:  Maryam Seyfhashemi; Raheb Ghorbani; Abbas Zolfaghari
Journal:  Iran Red Crescent Med J       Date:  2015-07-01       Impact factor: 0.611

2.  Urodynamic function during sleep-like brain states in urethane anesthetized rats.

Authors:  J Crook; T Lovick
Journal:  Neuroscience       Date:  2015-11-19       Impact factor: 3.590

3.  A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with Solifenacin Plus Desmopressin, Tolterodine Plus Desmopressin, and Desmopressin alone: a randomized controlled clinical trial.

Authors:  Parvin Mousavi Ghanavati; Dinyar Khazaeli; Mohammadreza Amjadzadeh
Journal:  Int Braz J Urol       Date:  2021 Jan-Feb       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.